We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App





MedTest Dx Releases New Product Line for Drugs of Abuse Testing

By LabMedica International staff writers
Posted on 06 Aug 2019
MedTest Dx, Inc. More...
(Canton, MI, USA) introduced an improved line of Clinitox Calibrators and Controls for confirmation testing at the 2019 American Association for Clinical Chemistry (AACC) Annual Scientific Meeting. The company’s new product line provides laboratories performing confirmation testing a comprehensive, reliable, easy-to-use and customizable calibration and controls solution designed for accuracy and efficiency, with extended shelf life and simplified documentation. At AACC 2019, MedTest also launched a new Certified Performance Guarantee Program for its Pointe Scientific branded line of clinical chemistry diagnostic reagents.

MedTest, which offers integrated products and services for clinical diagnostic testing, has a combination of screening instruments, reagent manufacturing, service capabilities and full LC/MS toxicology confirmation products. The MedTest Dx Clinitox Solution is a comprehensive key system enabling labs to bring drugs of abuse confirmation testing in-house by increasing the ease and efficiency of confirmation testing, while reducing the cost. It provides streamlined sample preparation; rapid implementation; Certificates of Analysis; documentation for traceability, including routine or specialty compound cut-offs; multiple panel options; and custom LC/MS calibrators, controls and internal standards.

Clinitox Calibrators and Controls are ready-to-use, liquid formats that simplify calibration and quality control procedures. They can be fully customized to meet the unique needs of individual laboratories, taking into consideration specific testing requirements, LC/MS instrumentation and sample matricies. Custom profiles are easily edited or updated as needs change. Clinitox Calibrators and Controls come as ready-to-use single use ampoules with batch and lot certifications, ensuring they deliver the quality laboratories require.

Additionally, MedTest’s Certified Performance Guarantee Program for its Pointe Scientific branded line of clinical chemistry diagnostic reagents that was introduced at AACC 2019 is intended to provide an additional layer of assurance to customers that the company stands fully behind the quality and reliability of every Pointe Scientific branded clinical chemistry reagent it ships. MedTest will issue a free replacement to any customer who is not fully satisfied with the performance of their Pointe Scientific branded reagent.

“We are very proud of Pointe Scientific’s well-established reputation as a quality leader in diagnostic reagents, and that its products are manufactured here in the US,” said Wayne Brinster, Chief Executive Officer of MedTest Dx. “Pointe Scientific offers an extensive line of cost-effective clinical chemistry reagents, some of which it was the first to introduce to the market. The company’s long record of successful innovation and consistent high quality made the decision to implement the Certified Performance Guarantee Program an easy one. We view the Guarantee program as indicative of our ongoing commitment to serving as our customers’ partner of choice for clinical diagnostic testing technologies.”

Related Links:
MedTest Dx


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
New
Gold Member
Fully-auto Specific Protein (Nephelometry) Analyzer
PA240
New
Fully Automated Urinalysis System
DxU 1800 Fully Automated Urinalysis System
Clinical Informatics Platform
CLARION™
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The researchers Manel Pérez Pons y Carlos Rodriguez Muñoz at the IRBLleida laboratory (Photo courtesy of IRBLleida)

New Blood RNA Markers Help Advance Precision Medicine for Respiratory Patients

Risk stratification in hospitalized respiratory disease, particularly among older adults with COVID-19, remains challenging despite rich clinical datasets. Blood-based non-coding RNA biomarkers are promising,... Read more

Microbiology

view channel
Image: The “broth” used to monitor red blood cell depletion in whole blood spiked with one colony-forming-unit of E. coli bacteria, each incubated at different orbital shaking speeds—left to right: 0 RPM, 65 RPM, 120 RPM and 200 RPM—after four hours of incubation. This culturing raises a bacteria-rich, plasma-like layer of bacteria to the top of the vials, while clusters of stuck blood cells known as a Rouleaux formation sink to the bottom. (Image Credit: Pak Kin Wong)

New Diagnostic Workflow Identifies Bloodstream Pathogens and Antibiotic Response in Hours

Sepsis is a life-threatening complication of infection that affects more than 1.5 million patients annually in the United States and contributes to roughly one in three in-hospital deaths.... Read more

Pathology

view channel
Image: Researchers evaluated AI models that quantify tumor-infiltrating lymphocytes (TIL) on routine breast tissue slides, where higher TIL levels reflect stronger antitumor response and improved breast cancer outcomes (Image Credit: Shutterstock)

AI Matches Pathologists in Predicting Breast Cancer Prognosis from Immune Cells

Breast cancer is the most common cancer in Australian women, with more than 20,000 cases each year. Prognosis can be informed by counting tumor-infiltrating lymphocytes (TILs) on routine pathology slides,... Read more

Industry

view channel
Image: RaDaR ST uses a tumor-informed approach that identifies up to 48 patient-specific variants through whole-exome sequencing and tracks those variants in plasma to detect circulating tumor DNA (ctDNA) at very low variant allele fractions (VAFs) (Photo courtesy of Neogenomics)

Tumor-Informed MRD Assay Gains Medicare Coverage for Immunotherapy Monitoring

NeoGenomics’ RaDaR ST molecular residual disease (MRD) assay has received expanded coverage from the Centers for Medicare & Medicaid Services’ Molecular Diagnostic Services Program (MolDX) for monitoring... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.